Thursday, Silo Pharma Inc (NASDAQ: SILO) provided an update on its previously announced dose-ranging study of SPC-15, a targeted prophylactic treatment for post-traumatic stress disorder (PTSD).
Apple has put a damper on its electric vehicle (EV) ambitions, while Chinese smartphone companies are aggressively moving forward, with Xiaomi making a significant entry into the EV market.
Agile Therapeutics, Inc. (NASDAQ:AGRX) ("Agile"), a women's healthcare company, today announced that its board of directors approved a 1-for-50 reverse stock split, to be effective 4:00 p.m. on
15-year accounting and finance career spans several sectors including life sciences and underscores financial leadership abilities
WEXFORD, Pa., May 17, 2023 /PRNewswire/ -- Coeptis Therapeutics Holdings, Inc.